TOPOISOMERASE-TARGETING ANTITUMOR DRUGS

[21] DAVIES SM, 1988, J BIOL CHEM, V263, P17724

[22] DEAVEN LL, 1978, J NATL CANCER I, V60, P1155

[23] DILLEHAY L E, 1988, NCI (National Cancer Institute) Monographs, P173

[24] DREWINKO B, 1982, CANCER RES, V42, P107

[25] DREWINKO B, 1976, CANCER TREAT REP, V60, P1295

[26] DREWINKO B, 1974, CANCER RES, V34, P747

[27] RECOGNITION SITES OF EUKARYOTIC DNA TOPOISOMERASE-I - DNA NUCLEOTIDE SEQUENCING ANALYSIS OF TOPO-I CLEAVAGE SITES ON SV40 DNA [J]. NUCLEIC ACIDS RESEARCH, 1982, 10 (08) : 2565 - 2576

[28] ENG WK, 1988, MOL PHARMACOL, V34, P755

[29] CELL-CYCLE STAGE DEPENDENT VARIATIONS IN DRUG-INDUCED TOPOISOMERASE-II MEDIATED DNA CLEAVAGE AND CYTOTOXICITY [J]. BIOCHEMISTRY, 1987, 26 (14) : 4338 - 4344

[30] THE INTERACTION BETWEEN NUCLEAR TOPOISOMERASE-II ACTIVITY FROM HUMAN-LEUKEMIA CELLS, EXOGENOUS DNA, AND 4'-(9-ACRIDINYLAMINO) METHANESULFON-M-ANISIDIDE (M-AMSA) OR 4-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (VP-16) INDICATES THE SENSITIVITY OF THE CELLS TO THE DRUGS [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 144 (02) : 787 - 793

[21] DAVIES SM, 1988, J BIOL CHEM, V263, P17724

[22] DEAVEN LL, 1978, J NATL CANCER I, V60, P1155

[23] DILLEHAY L E, 1988, NCI (National Cancer Institute) Monographs, P173

[24] DREWINKO B, 1982, CANCER RES, V42, P107

[25] DREWINKO B, 1976, CANCER TREAT REP, V60, P1295

[26] DREWINKO B, 1974, CANCER RES, V34, P747

[27] RECOGNITION SITES OF EUKARYOTIC DNA TOPOISOMERASE-I - DNA NUCLEOTIDE SEQUENCING ANALYSIS OF TOPO-I CLEAVAGE SITES ON SV40 DNA [J]. NUCLEIC ACIDS RESEARCH, 1982, 10 (08) : 2565 - 2576

[28] ENG WK, 1988, MOL PHARMACOL, V34, P755

[29] CELL-CYCLE STAGE DEPENDENT VARIATIONS IN DRUG-INDUCED TOPOISOMERASE-II MEDIATED DNA CLEAVAGE AND CYTOTOXICITY [J]. BIOCHEMISTRY, 1987, 26 (14) : 4338 - 4344

[30] THE INTERACTION BETWEEN NUCLEAR TOPOISOMERASE-II ACTIVITY FROM HUMAN-LEUKEMIA CELLS, EXOGENOUS DNA, AND 4'-(9-ACRIDINYLAMINO) METHANESULFON-M-ANISIDIDE (M-AMSA) OR 4-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (VP-16) INDICATES THE SENSITIVITY OF THE CELLS TO THE DRUGS [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 144 (02) : 787 - 793